Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on November 16, 2006

Arteriosclerosis, Thrombosis, and Vascular Biology. 2006
Published online before print November 16, 2006, doi: 10.1161/01.ATV.0000252826.96134.21
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/2/422    most recent
01.ATV.0000252826.96134.21v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughan, S. C.
Right arrow Articles by Watson, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughan, S. C.
Right arrow Articles by Watson, S. P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-TYROSINE

Submitted on May 31, 2006
Accepted on October 31, 2006

GPVI Potentiation of Platelet Activation by Thrombin and Adhesion Molecules Independent of Src Kinases and Syk

Sascha C. Hughan *; Craig E. Hughes ; Owen J.T. McCarty ; Edina Schweighoffer ; Izoumroud Soultanova ; Jerry Ware ; Victor L.J. Tybulewicz ; and Steve P. Watson

From the Centre for Cardiovascular Sciences (S.C.H., C.E.H., O.J.T.M., S.P.W.), Institute of Biomedical Research, University of Birmingham, UK; the National Institute for Medical Research (E.S., V.L.J.T.), London, UK; Australian Centre for Blood Diseases (S.C.H.), Monash University, Melbourne, Victoria, Australia; and the Department of Physiology and Biophysics (I.S., J.W.), University of Arkansas for Medical Sciences, Little Rock. Current affiliation for O.J.T.M.: Department of Biomedical Engineering, Oregon Health and Science University, Portland, Ore.

* To whom correspondence should be addressed. E-mail: Sascha.hughan{at}med.monash.edu.au.

Objective--The present study investigates the role of Src and Syk tyrosine kinases in signaling by G-protein coupled and platelet adhesion receptors.

Methods and Results--Using Syk-/- platelets or the Src kinase inhibitor PP2, we demonstrate a critical role for Src and Syk kinases in mediating lamellipodia formation on VWF, collagen, CRP, fibrinogen, and fibronectin. In all cases, the spreading defect was overcome by addition of thrombin. Conversely, platelet aggregation and {alpha}IIb{beta}3 activation induced by thrombin was similar to controls, arguing against a functional role for Src and Syk in {alpha}IIb{beta}3 activation. Unexpectedly, CRP potentiated integrin {alpha}IIb{beta}3 activation and platelet aggregation induced by subthreshold concentrations of thrombin in Syk-/- platelets or in the presence of the Src kinase inhibitor PP2. Potentiation in the presence of PP2 was lost in the absence of FcR{gamma}-chain or GPVI confirming that it was mediated through the immunoglobulin receptor. Further delineation of this PP2-resistant synergy revealed that PAR4 could trigger the enhanced response in combination with CRP.

Conclusions--We show that Syk is critical for lamellipodia formation on a range of immobilized proteins but that this can be overcome by addition of thrombin. Further, we reveal a novel role for GPVI in supporting thrombin-induced activation, independent of Syk and Src kinases.


Key words: platelets • GPVI signaling • Src kinases • Syk • thrombin




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. A. Karim, W. Choi, and S. W. Whiteheart
Primary Platelet Signaling Cascades and Integrin-mediated Signaling Control ADP-ribosylation Factor (Arf) 6-GTP Levels during Platelet Activation and Aggregation
J. Biol. Chem., May 2, 2008; 283(18): 11995 - 12003.
[Abstract] [Full Text] [PDF]